Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation
Osama Mehanna,1,2 Ahmad El Askary,3,4 Ebtesam Ali,5 Basem El Esawy,3,6 Tamer FathAlla,7 Amal F Gharib3,8 1Department of Medical Physiology, College of Medicine, Taif University, Taif 21944, Saudi Arabia; 2Department of Medical Physiology, Faculty of Medicine, Al-Azhar University, New Damietta, Egypt...
Guardado en:
Autores principales: | Mehanna O, El Askary A, Ali E, El Esawy B, FathAlla T, Gharib AF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1462dcf5237540d5b0f02f06c0487f4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
por: DiBonaventura MD, et al.
Publicado: (2017) -
COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
por: Zhu X, et al.
Publicado: (2020) -
Comorbidity Profiles among Obese–Diabetic End-Stage Renal Disease Patients: Data from REIN Registry of PACA Region of France
por: Kakar A, et al.
Publicado: (2021) -
Obesity and brain illness: from cognitive and psychological evidences to obesity paradox
por: Monda V, et al.
Publicado: (2017) -
Obesity and morbid obesity associated with higher odds of hypoalbuminemia in adults without liver disease or renal failure
por: Mosli RH, et al.
Publicado: (2017)